Clinical Trials Insight: 700023973
Phase of Trial: Phase I
Latest Information Update: 28 Feb 2008
At a glance
- Drugs Alvespimycin; Trastuzumab
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Kosan Biosciences
- 28 Feb 2008 Kosan has reported that this trial will be discontinued.
- 10 Sep 2007 Interim results in 23 patients with HER2-positive breast cancer and 3 patients with ovarian cancer were presented at the ASCO Breast Cancer Symposium in September 2007 (9079856).
- 20 Jun 2007 New trial record.